CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +11,695 | 306,051 | ||
| 2026-10-31 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −3,327 | $0.28 | $932 | 302,724 |
| 2026-10-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −11,695 | 105,249 | ||
| 2026-10-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +13,535 | 298,206 | ||
| 2026-10-30 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −3,850 | $0.28 | $1K | 294,356 |
| 2026-10-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −13,535 | 175,957 | ||
| 2026-10-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +3,874 | 285,773 | ||
| 2026-10-19 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −1,102 | $0.36 | $397 | 284,671 |
| 2026-10-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −3,874 | 19,372 | ||
| 2026-07-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +11,694 | 285,225 | ||
| 2026-07-31 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −3,326 | $0.50 | $2K | 281,899 |
| 2026-07-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −11,694 | 116,944 | ||
| 2026-07-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +13,535 | 277,381 | ||
| 2026-07-30 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −3,850 | $0.50 | $2K | 273,531 |
| 2026-07-30 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −13,535 | 189,492 | ||
| 2026-07-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +3,874 | 264,947 | ||
| 2026-07-19 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −1,101 | $0.47 | $517 | 263,846 |
| 2026-07-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −3,874 | 23,246 | ||
| 2026-06-16 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +12,500 | 264,628 | ||
| 2026-06-16 | Duarte Ira EVP, Chief Financial Officer | Shares withheld for taxes | −3,555 | $0.38 | $1K | 261,073 |
Page 1 of 4 · 63 trades